Get the latest Science News and Discoveries
New PET agent provides exceptional same-day imaging for clear cell renal cell carcinoma patients - EurekAlert
A novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients according to new research published in the May issue of <em>The Journal of Nuclear Medicine</em>. The results of the study suggest that the agent <sup>68</sup>Ga-DPI-4452 (Debio 0328) is superior to standard CT imaging in the context of ccRCC. It also allows for significantly faster imaging and, in the future, could be utilized as part of a theranostic pair.
None
Or read this on Eureka Alert